Michael John Sumner
CIK: 0001936799
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
INOVIO PHARMACEUTICALS, INC.
Discretionary Trading P&L
Holdings
Transaction History (23 total)
- May 20, 2026INO
INOVIO PHARMACEUTICALS, INC.
Award(A)DirectCommon Stock Option
46.9K shares- - May 20, 2026INO
INOVIO PHARMACEUTICALS, INC.
Award(A)DirectRestricted Stock Unit
37.7K shares- - May 20, 2026INO
INOVIO PHARMACEUTICALS, INC.
Exercise(M)Direct9.5K shares- - May 20, 2026INO
INOVIO PHARMACEUTICALS, INC.
Tax Payment(F)Direct2.7K shares at avg. $1.23$3K - May 15, 2026INO
INOVIO PHARMACEUTICALS, INC.
Exercise(M)Direct2.4K shares- - May 15, 2026INO
INOVIO PHARMACEUTICALS, INC.
Tax Payment(F)Direct680 shares at avg. $1.30$884 - Mar 31, 2026INO
INOVIO PHARMACEUTICALS, INC.
Exercise(M)Direct4.3K shares- - Mar 31, 2026INO
INOVIO PHARMACEUTICALS, INC.
Tax Payment(F)Direct1.2K shares at avg. $1.74$2K - Mar 4, 2026INO
INOVIO PHARMACEUTICALS, INC.
Award(A)DirectRestricted Stock Unit
29.6K shares- - Mar 4, 2026INO
INOVIO PHARMACEUTICALS, INC.
Award(A)DirectCommon Stock Option
36.8K shares- - Feb 26, 2026INO
INOVIO PHARMACEUTICALS, INC.
Exercise(M)Direct11.6K shares- - Feb 26, 2026INO
INOVIO PHARMACEUTICALS, INC.
Exercise(M)Direct5K shares- - Feb 26, 2026INO
INOVIO PHARMACEUTICALS, INC.
Tax Payment(F)Direct3.9K shares at avg. $1.79$7K - Jun 30, 2025INO
INOVIO PHARMACEUTICALS, INC.
Exercise(M)Direct2.9K shares- - May 20, 2025INO
INOVIO PHARMACEUTICALS, INC.
Award(A)DirectCommon Stock Option
35.1K shares- - May 20, 2025INO
INOVIO PHARMACEUTICALS, INC.
Award(A)DirectRestricted Stock Unit
28.4K shares- - May 15, 2025INO
INOVIO PHARMACEUTICALS, INC.
Tax Payment(F)Direct680 shares at avg. $1.95$1K - May 15, 2025INO
INOVIO PHARMACEUTICALS, INC.
Exercise(M)Direct2.4K shares- - Feb 27, 2025INO
INOVIO PHARMACEUTICALS, INC.
Award(A)DirectCommon Stock Option
42.9K shares- - Feb 27, 2025INO
INOVIO PHARMACEUTICALS, INC.
Award(A)DirectRestricted Stock Unit
34.7K shares- - Feb 26, 2025INO
INOVIO PHARMACEUTICALS, INC.
Exercise(M)Direct5K shares- - Dec 18, 2024INO
INOVIO PHARMACEUTICALS, INC.
Award(A)DirectRestricted Stock Unit
4.3K shares- - Dec 18, 2024INO
INOVIO PHARMACEUTICALS, INC.
Award(A)DirectCommon Stock Option
5.7K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| May 20, 2026 | INO INOVIO PHARMACEUTICALS, INC. | Award(A) Common Stock Option | 46,876 | - | - | Direct |
| May 20, 2026 | INO INOVIO PHARMACEUTICALS, INC. | Award(A) Restricted Stock Unit | 37,684 | - | - | Direct |
| May 20, 2026 | INO INOVIO PHARMACEUTICALS, INC. | Exercise(M) | 9,450 | - | $0 | Direct |
| May 20, 2026 | INO INOVIO PHARMACEUTICALS, INC. | Tax Payment(F) | 2,693 | $1.23 | $3,312 | Direct |
| May 15, 2026 | INO INOVIO PHARMACEUTICALS, INC. | Exercise(M) | 2,385 | - | $0 | Direct |
| May 15, 2026 | INO INOVIO PHARMACEUTICALS, INC. | Tax Payment(F) | 680 | $1.30 | $884 | Direct |
| Mar 31, 2026 | INO INOVIO PHARMACEUTICALS, INC. | Exercise(M) | 4,292 | - | $0 | Direct |
| Mar 31, 2026 | INO INOVIO PHARMACEUTICALS, INC. | Tax Payment(F) | 1,223 | $1.74 | $2,128 | Direct |
| Mar 4, 2026 | INO INOVIO PHARMACEUTICALS, INC. | Award(A) Restricted Stock Unit | 29,608 | - | - | Direct |
| Mar 4, 2026 | INO INOVIO PHARMACEUTICALS, INC. | Award(A) Common Stock Option | 36,832 | - | - | Direct |
| Feb 26, 2026 | INO INOVIO PHARMACEUTICALS, INC. | Exercise(M) | 11,550 | - | $0 | Direct |
| Feb 26, 2026 | INO INOVIO PHARMACEUTICALS, INC. | Exercise(M) | 5,010 | - | $0 | Direct |
| Feb 26, 2026 | INO INOVIO PHARMACEUTICALS, INC. | Tax Payment(F) | 3,903 | $1.79 | $6,986 | Direct |
| Jun 30, 2025 | INO INOVIO PHARMACEUTICALS, INC. | Exercise(M) | 2,916 | - | - | Direct |
| May 20, 2025 | INO INOVIO PHARMACEUTICALS, INC. | Award(A) Common Stock Option | 35,100 | - | - | Direct |
| May 20, 2025 | INO INOVIO PHARMACEUTICALS, INC. | Award(A) Restricted Stock Unit | 28,350 | - | - | Direct |
| May 15, 2025 | INO INOVIO PHARMACEUTICALS, INC. | Tax Payment(F) | 680 | $1.95 | $1,326 | Direct |
| May 15, 2025 | INO INOVIO PHARMACEUTICALS, INC. | Exercise(M) | 2,385 | - | - | Direct |
| Feb 27, 2025 | INO INOVIO PHARMACEUTICALS, INC. | Award(A) Common Stock Option | 42,900 | - | - | Direct |
| Feb 27, 2025 | INO INOVIO PHARMACEUTICALS, INC. | Award(A) Restricted Stock Unit | 34,650 | - | - | Direct |
| Feb 26, 2025 | INO INOVIO PHARMACEUTICALS, INC. | Exercise(M) | 5,010 | - | - | Direct |
| Dec 18, 2024 | INO INOVIO PHARMACEUTICALS, INC. | Award(A) Restricted Stock Unit | 4,292 | - | - | Direct |
| Dec 18, 2024 | INO INOVIO PHARMACEUTICALS, INC. | Award(A) Common Stock Option | 5,708 | - | - | Direct |
1-23 of 23 transactions
About Sumner Michael John
Sumner Michael John (SEC CIK 0001936799) files insider reports with the SEC as Chief Medical Officer of INOVIO PHARMACEUTICALS, INC. (INO).
Signal8 holds 10 ownership filings by Sumner Michael John, all Form 4s, filed between Dec 18, 2024 and May 21, 2026. Those filings report 23 transactions, from Dec 18, 2024 to May 20, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Sumner Michael John's filings is in PLYMOUTH MEETING, PA.
Recent filings by Sumner Michael John
- May 20, 2026: Grants or awards of INO derivative securities (2 lines, Form 4, code A).
- May 20, 2026: Option exercise of INO shares (Form 4, code M).
- May 20, 2026: Tax withholding of INO shares (Form 4, code F).
- May 15, 2026: Option exercise of INO shares (Form 4, code M).
- May 15, 2026: Tax withholding of INO shares (Form 4, code F).
Other insiders filing for INOVIO PHARMACEUTICALS, INC. (INO)
- YARNO WENDY L, Director
- Shepard Jay, Director
- Miller Ann Calby, Director
- Weiner David B., Director
- Zoth Lota S., Director
- DANSEY ROGER D, Director